We focus on the most likely growth clusters in 2020s in digitalization, healthcare/demographics and sustainable/renewables.
We invest in high quality biotech companies with regulatory tailwind from the FDA. The primary focus of the fund is companies with Breakthrough designation in cancer, imunnooncology and genetherapy
We invest in global large cap companies. Our investment philosophy is focused on stable growth stock with a strong marketshare or moat, with a dynamic management team.